In a major scientific breakthrough, researchers at Mayo Clinic’s Center for Individualized Medicine have identified a rare ...

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

Scientists found a compound that appears to counter common mutations behind POLG-related diseases, rare conditions that harm ...

A new, groundbreaking clinical trial has shown results that may soon replace surgery and other treatments like chemotherapy ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

The US Food and Drug Administration (FDA) has granted rare paediatric disease and orphan drug designations for IN013, Innorna ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel ...

A groundbreaking clinical trial replaces surgery with immunotherapy for cancer patients. The results could change cancer treatment, offering new hope for those with specific genetic mutations.

Organoids, miniaturized, stem cell-derived versions of human organs, are revolutionizing biomedical research by offering human-specific models for disease study and drug testing. While they have ...